Nine Predictions for AI in 2026, from the Father of AGI 
Smarter Identity Verification in the Age of AI Fraud 
Ourbit Accelerates Cross-Market Strategy with Commodities, Tokenised Stocks and Big Rewards OKYO Pharma Limited: Directorate Change
LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (“OKYO” or the “Company”) today…
Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline of innovative vaccine candidates
Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline…
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based…
Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases
TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the…
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
HALIFAX, Nova Scotia, Nov. 30, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
PITTSBURGH, Nov. 30, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the…
Oyster Point Pharma to Participate in the Piper Sandler 33rd Annual Healthcare Conference
PRINCETON, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Molecular Templates Provides Corporate Update and Outlines 2022 Milestones
Unique PD-L1-mediated immune changes and early signs of anti-tumor activity with MT-6402 Continued dose-finding with…
Illuccix® Granted Use Authorisation for Prostate Cancer Imaging in Brazil
MELBOURNE, Australia and PORTO ALEGRE, Brazil, Nov. 30, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited…
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021
TUSTIN, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…
Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty Patients
New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and…
ACCUSTEM SCIENCES LIMITED (‘ACCUSTEM UK’) and ACCUSTEM SCIENCES INC (‘ACCUSTEM US’) Recommended corporate reorganisation by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006
COURT SANCTIONS THE SCHEME OF ARRANGEMENT LONDON, Nov. 30, 2021 (GLOBE NEWSWIRE) — Reference is…
Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021
Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies,…
Eurobio Scientific Launches the First Pcr Test Allowing Simultaneous Sars-Cov-2 Virus Screening and Detection of the Delta and Omicron Variants in a Single Reaction
EUROBIO SCIENTIFIC LAUNCHES THE FIRST PCR TEST ALLOWING SIMULTANEOUS SARS-COV-2 VIRUS SCREENING AND DETECTION OF…
Launch of accelerated bookbuild offering of up to 1,300,000 existing shares in NTG Nordic Transport Group A/S
Company announcement no. 23 – 2130 November 2021 NOT FOR DISTRIBUTION IN THE UNITED STATES,…
Total number of shares and voting rights in Zealand Pharma at November 30, 2021
Company announcement – No. 72 / 2021 Total number of shares and voting rights in Zealand…
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of…
Biofrontera Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
Conference call at 4:30 p.m. Eastern time today WOBURN, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE)…
23andMe Announces the Appointment of Joseph R. Arron, M.D., Ph.D. as Chief Scientific Officer
Dr. Arron brings nearly two decades of scientific leadership in biotech drug discovery and development…
Clarus Therapeutics Announces Issuance of Two New Patents for JATENZO® (testosterone undecanoate)
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in…